The results of the Phase 1 study, led by a researcher at NYU Langone Health and its Perlmutter Cancer Center, were announced on Friday, adding to the growing body of research into oncolytic viruses.

Your most Authoritative news site
The results of the Phase 1 study, led by a researcher at NYU Langone Health and its Perlmutter Cancer Center, were announced on Friday, adding to the growing body of research into oncolytic viruses.